Found: 12
Select item for more details and to access through your institution.
Efficacy of Alogliptin/Metformin Fixed-Dose Combination Tablets and Vildagliptin/Metformin Fixed-Dose Combination Tablets on Glycemic Control in Real-World Clinical Practice for the Patients with Type 2 Diabetes: A Multicenter, Open-Label, Randomized, Parallel Group, Comparative Trial
- Published in:
- Metabolic Syndrome & Related Disorders, 2024, v. 22, n. 9, p. 651, doi. 10.1089/met.2024.0127
- By:
- Publication type:
- Article
A maternal high-fat diet induces fetal origins of NASH-HCC in mice.
- Published in:
- Scientific Reports, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41598-022-17501-8
- By:
- Publication type:
- Article
Establishment of novel specific assay for short‐form glucose‐dependent insulinotropic polypeptide and evaluation of its secretion in nondiabetic subjects.
- Published in:
- Physiological Reports, 2020, v. 8, n. 11, p. 1, doi. 10.14814/phy2.14469
- By:
- Publication type:
- Article
Hypoxia-inducible factor-1α is the therapeutic target of the SGLT2 inhibitor for diabetic nephropathy.
- Published in:
- Scientific Reports, 2019, v. 9, n. 1, p. N.PAG, doi. 10.1038/s41598-019-51343-1
- By:
- Publication type:
- Article
A case of insulinoma diagnosed postpartum with hypoglycemic symptoms that were masked during pregnancy.
- Published in:
- Clinical Case Reports, 2021, v. 9, n. 4, p. 1991, doi. 10.1002/ccr3.3924
- By:
- Publication type:
- Article
Increment of plasma glucose by exogenous glucagon is associated with present and future renal function in type 2 diabetes:a retrospective study from glucagon stimulation test.
- Published in:
- BMC Endocrine Disorders, 2019, v. 19, n. 1, p. N.PAG, doi. 10.1186/s12902-019-0428-6
- By:
- Publication type:
- Article
391-P: The Nrf2 Activator Increases TFAM and Suppresses STING in Human Renal Proximal Tubular Cells.
- Published in:
- Diabetes, 2021, v. 70, p. N.PAG, doi. 10.2337/db21-391-P
- By:
- Publication type:
- Article
1171-P: HORMAD1, a Novel Hypoxia-Inducible Factor-1 Target, Is Upregulated in Maternal Overnutrition-Induced Nonalcoholic Steatohepatitis (NASH)/Hepatocellular Carcinoma.
- Published in:
- Diabetes, 2021, v. 70, p. N.PAG, doi. 10.2337/db21-1171-P
- By:
- Publication type:
- Article
1845-P: Maternal Overnutrition Causes DNA Alkylation in Fetal Liver, Suppresses FasL, and Upregulates HIF-1 Signaling Pathway in Neonatal Liver in Nonalcoholic Steatohepatitis (NASH)-Based Hepatocellular Carcinoma in Offspring.
- Published in:
- Diabetes, 2020, v. 69, p. N.PAG, doi. 10.2337/db20-1845-P
- By:
- Publication type:
- Article
493-P: Synchrotron Radiation Micro-CT Reveals Glomerular Loss without Glomerular or Renal Hypertrophy in Streptozotocin-Induced Type 1 Diabetic Mice.
- Published in:
- Diabetes, 2019, v. 68, p. N.PAG, doi. 10.2337/db19-493-P
- By:
- Publication type:
- Article
492-P: A Novel Renoprotective Target of SGLT2 Inhibitor: HIF-1α Inhibition and AMPK Activation in Renal Proximal Tubular Epithelial Cells.
- Published in:
- Diabetes, 2019, v. 68, p. N.PAG, doi. 10.2337/db19-492-P
- By:
- Publication type:
- Article
1948-P: Secretion of the Short-Form Gastric Inhibitory Polypeptide in Nondiabetic and Diabetic Subjects.
- Published in:
- Diabetes, 2019, v. 68, p. N.PAG, doi. 10.2337/db19-1948-P
- By:
- Publication type:
- Article